Date |
Topic |
2008 |
October 29 |
MedKit for the treatment or prophylaxis of pandemic influenza |
2007 |
December 14 |
Effectiveness of Phenylephrine as an oral nasal decongestant |
December 13 |
Rx-to- OTC Switch of Mevacor (lovastatin) for cholesterol reduction |
October 18-19 |
Pediatric Use of Cold and Cough Products |
2006 |
September 25 |
Actual use and label comprehension studies |
January 24 |
Epinephrine products containing CFCs |
January 23 |
Rx-to-OTC switch of Orlistat (tetrahydrolipstatin) for weight loss |
2005 |
March 24 |
Topical corticosteriods: safety studies needed for Rx-to-OTC switch |
March 23 |
Healthcare antiseptics: testing method |
January 13 - 14 |
Rx-to-OTC switch of Mevacor (lovastatin) for cholesterol reduction |
2004 |
May 6 - 7 |
Athlete’s foot: efficacy & labeling of antifungals |
2003 |
December 16 |
Rx-to-OTC switch of Plan B (levonorgestrel) for emergency contraception |
December 8 |
Aspirin: primary prevention of myocardial infarction |
June 12 |
OTC status of ipecac syrup for emergency poison treatment |
2002 |
September 19 - 20 |
Internal Analgesics: organ-specific warnings |
June 21 |
Rx-to-OTC switch of Prilosec (omeprazole) for heartburn relief |
April 22 |
Rx-to-OTC switch of Claritin (loratadine) for relief of allergic rhinitis |
2001 |
May 11 |
Rx-to-OTC switch of fexofenadine, loratadine, & cetrizine for relief of allergic rhinitis |
2000 |
October 20 |
Rx-to-OTC switch of Prilosec (omeprazole) for heartburn relief |
October 19 |
Phenylpropanolamine (PPA) safety |
July 14 |
Rx-to-OTC switch of Pravachol (pravastatin) for cholesterol reduction |
July 13 |
Rx-to-OTC switch of Mevacor (lovastatin) for cholesterol reduction |
July 12 |
Remarketing & labeling of Today Sponge as vaginal contraceptive |
1999 |
July 20 |
Rx-to-OTC switch of Flexeril (cyclobenzaprine) for muscle pain relief |
1998 |
December 2 - 3 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
December 1 |
Rx-to-OTC switch of Denavir (herpes labilis) |
October 22 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
September 11 |
Class labeling for vaginal antifungals |
July 29 |
Final formulation testing for healthcare antiseptics |
July 28 |
Class labeling for vaginal antifungals |
May 27 - 29 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
1997 |
October 29 - 30 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
September 18 |
Pediatric analgesic/antipyretic dosing and labeling |
July 16 |
Rx-to-OTC switch of Rogaine (minoxidil) as hair growth stimulant |
July 15 |
Rx-to-OTC switch of Excedrin Extra Strength (acetaminophen, aspirin, caffeine) for migraine relief |
July 14 |
Drug Facts labeling |
May 13 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of Questran (cholesyramine resin) and Questran Light for cholesterol reduction |
May 8-9 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
April 15 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Vaginal douching safety |
January 23 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Aspirin professional labeling |
January 22 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Healthcare continuum model for regulation of healthcare antiseptic drug products |
1996 |
November 22 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Clinical efficacy studies for vaginal spermicides |
November 21 |
Vaginal products to prevent HIV transmission |
November 20 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Antimicrobial topical vaginal agents for STD prevention |
October 10 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of Nasalcrom (cromolyn sodium) for allergic rhinitis relief |
October 9 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of S+ Ibuprofen (dexibuprofen) as analgesic/antipyretic |
September 19 - 20 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Photochemistry and Photobiology of Sunscreens (Public Meeting) |
June 7 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
June 6 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Alcohol content of oral healthcare mouthwashes |
April 19 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of Nicotrol (nicotine transdermal system) for smoking cessation |
1995 |
December 4 - 5 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
November 17 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of Rogaine (minoxidil) as hair growth stimulant |
November 16 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Common cold indication (focus on clemastine fumarate) |
September 29 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
OTC drug labeling (discussion of Public Hearing) |
September 28 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of Nicorette (nicotine polacrilex); nizatidine |
September 27 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of Questran (cholestyramine) for cholesterol reduction |
August 14 - 15 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
April 10 - 12 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
March 28 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Motrin: pediatric use OTC muscle relaxant |
March 27 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of Tagamet (cimetidine) for heartburn relief |
January 13 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Pediatric dosing of OTC drug products |
January 12 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of Zovirax (acyclovir) to treat genital herpes |
January 11 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Closed meeting |
1994 |
December 5 - 7 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
November 16 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Antibiotic resistance of topical erythromycin to treat acne |
November 14 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
OTC status of antiasthmatic drugs |
October 11 - 12 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
September 8 - 9 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
OTC analgesics: efficacy testing & labeling |
July 29 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of Pepcid (famotidine) for relief of episodic heartburn |
July 27 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of Rogaine (minoxidil) |
May 19 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Rx-to-OTC switch of acyclovir for management of recurrent genital herpes (Part 15 hearing) |
1993 |
September 8 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Alcohol and OTC internal analgesic medications (other than acetaminophen) |
June 29 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Alcohol and acetaminophen: liver toxicity |
June 28 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Labeling of doxylamine succinate regarding tumor development in animals; Advertising of OTC drugs by FTC |
June 2 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Closed meeting |
June 1 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Juvenile rheumatoid arthritis guidelines; Rx-to-OTC switch of Naprosyn (naproxen) |
April 9 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Antidiarrheal drugs containing attapulgite, kaolin, pectin |
April 8 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Role and appropriate doses of caffeine as an adjuvant in internal analgesic drug products |
1992 |
December 17 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Benefits and risks of alcohol in oral OTC drug products |
December 16 ![PDF document](https://webarchive.library.unt.edu/eot2008/20090117203545im_/http://www.fda.gov/cder/graphics/pdf.gif) |
Role of NDAC in the regulation of nonprescription products |